Screening Phase
Item
screening phase:
boolean
C0220908 (UMLS CUI [1,1])
C1710475 (UMLS CUI [1,2])
Age
Item
age 21 or older.
boolean
C0001779 (UMLS CUI [1])
Breast Carcinoma TNM Breast tumor staging
Item
histologically proven stage i-iii carcinoma of the breast.
boolean
C0678222 (UMLS CUI [1,1])
C0474926 (UMLS CUI [1,2])
Adjuvant Chemotherapy Planned | Chemotherapy Neoadjuvant Planned | Paclitaxel Weekly
Item
plan to receive adjuvant or neoadjuvant chemotherapy that includes weekly paclitaxel.
boolean
C0085533 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C0600558 (UMLS CUI [2,2])
C1301732 (UMLS CUI [2,3])
C0144576 (UMLS CUI [3,1])
C0332174 (UMLS CUI [3,2])
ECOG performance status
Item
eastern cooperative oncology group performance status 0-2 (see appendix b).
boolean
C1520224 (UMLS CUI [1])
Informed Consent
Item
the patient is aware of the nature of his/her diagnosis, understands the study regimen, its requirements, risks, and discomforts, and is able and willing to sign an informed consent form.
boolean
C0021430 (UMLS CUI [1])
Able to speak English Language | Able to read English Language
Item
proficiency in english with the ability to speak and read english.
boolean
C0564215 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
C0586740 (UMLS CUI [2,1])
C0376245 (UMLS CUI [2,2])
Intervention Phase
Item
intervention phase:
boolean
C0184661 (UMLS CUI [1,1])
C1710475 (UMLS CUI [1,2])
Age
Item
age 21 or older.
boolean
C0001779 (UMLS CUI [1])
Breast Carcinoma TNM Breast tumor staging
Item
histologically proven stage i-iii carcinoma of the breast.
boolean
C0678222 (UMLS CUI [1,1])
C0474926 (UMLS CUI [1,2])
Chemotherapy, Adjuvant | Chemotherapy Neoadjuvant | taxane
Item
receiving adjuvant or neoadjuvant chemotherapy that includes a taxane.
boolean
C0085533 (UMLS CUI [1])
C0392920 (UMLS CUI [2,1])
C0600558 (UMLS CUI [2,2])
C0215136 (UMLS CUI [3])
ECOG performance status
Item
eastern cooperative oncology group performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Informed Consent
Item
the patient is aware of the nature of his/her diagnosis, understands the study regimen, its requirements, risks, and discomforts, and is able and willing to sign an informed consent form.
boolean
C0021430 (UMLS CUI [1])
Able to speak English Language | Able to read English Language
Item
proficiency in english with the ability to speak and read english
boolean
C0564215 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
C0586740 (UMLS CUI [2,1])
C0376245 (UMLS CUI [2,2])
Chemotherapy | Neurotoxicity CTCAE Grades
Item
while on neurotoxic chemotherapy, has developed nci-ctc grade 2 cipn
boolean
C0392920 (UMLS CUI [1])
C0235032 (UMLS CUI [2,1])
C1516728 (UMLS CUI [2,2])
Secondary malignant neoplasm of female breast Involvement
Item
known metastatic (stage iv) breast cancer involvement.
boolean
C0346993 (UMLS CUI [1,1])
C1314939 (UMLS CUI [1,2])
Peripheral Neuropathy Pre-existing
Item
pre-existing peripheral neuropathy before chemotherapy is initiated.
boolean
C0031117 (UMLS CUI [1,1])
C2347662 (UMLS CUI [1,2])
Pharmaceutical Preparations Against Neuropathy | gabapentin | pregabalin | duloxetine | Glutamine
Item
currently taking anti-neuropathy medication such as gabapentin, pregabalin, duloxetine, or glutamine.
boolean
C0013227 (UMLS CUI [1,1])
C0521124 (UMLS CUI [1,2])
C0442874 (UMLS CUI [1,3])
C0060926 (UMLS CUI [2])
C0657912 (UMLS CUI [3])
C0245561 (UMLS CUI [4])
C0017797 (UMLS CUI [5])